Noom Med Billing Terms: Quarterly Commitment and Prepay Structure

Last reviewed: September 23, 2026 Last updated: September 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Noom Med's publicly available pricing pages describe its billing structure—quarterly prepayment of $387 for the core clinical program after the first month, and monthly billing at $179 for the ongoing microdose GLP-1Rx subscription following a $79 first-month period—but they do not publish specific cancellation deadlines, refund policies for prepaid quarters, or mid-cycle termination terms. The medication cost is excluded from the core program fee. If you need transparency around exit mechanics before committing to a prepaid quarter, confirm those details directly with Noom Med support or compare against month-to-month alternatives that carry no prepayment requirement.

Billing structure at a glance

Noom Med pricing captured September 4, 2026 from public pricing pages; PlexusDx pricing current as of September 23, 2026.

What the quarterly billing structure means in practice

Noom Med's core clinical program moves to quarterly prepayment after the first month: you pay $387 upfront to cover the next three months of behavioral coaching, clinician access, and program support. Medication remains a separate line item, billed according to your prescription and formulary tier. The quarterly structure spreads to $129 per month on paper, but you commit that amount in a single transaction every 90 days.

The microdose GLP-1Rx track follows a different pattern. The first-month period costs $79 and covers approximately seven weeks—a three-week subscription plus four weeks of medication. After that, the subscription shifts to $179 per month on a 12-week cycle, with medication included in the subscription fee during the first month and handled within the ongoing subscription structure thereafter.

Neither the core program page nor the microdose offer page captured in our verification session (September 4, 2026) disclosed cancellation notice periods, whether prepaid quarters are refundable or prorated if you cancel mid-cycle, or how auto-renewal works at the end of each billing period. The phrase "after first month; quarterly billing" describes the cadence but not the exit mechanics.

Cost over 12 months, normalized

To compare economic commitment across programs, we calculate total spending over one year assuming continuous enrollment and no dosage changes. All figures below are our calculation unless otherwise noted.

Noom Med Core (medication excluded)

• Quarterly billing: $387 × 4 quarters = $1,548 per year, averaged to $129/month.
• First-month pricing was not captured; this assumes quarterly prepayment begins in month two.
• Medication is billed separately and will add to this total; branded GLP-1 list prices often exceed $1,000 per month without insurance, though Noom Med also offers compounded formulations under its GLP-1Rx Plus and microdose programs.

Noom Med Microdose GLP-1Rx

• First-month rate: $79 (covers ~7 weeks)
• Ongoing: $179/month × 10.75 remaining months = $1,924 (our calculation)
• 12-month total: $79 + $1,924 = $2,003, averaged to $167/month over the year.
• Medication is included in both the first-month and ongoing subscription fees for this track.

PlexusDx Microdose GLP-1 (month-to-month)

• $129/month × 12 = $1,548 per year, averaged to $129/month.
• Medication, provider visits, and shipping included; no separate charges.

PlexusDx Semaglutide Injection (month-to-month)

• $189/month × 12 = $2,268 per year, averaged to $189/month.
• Medication, provider visits, and shipping included; no separate charges.

Over 12 months, Noom Med's microdose program costs approximately $455 more than PlexusDx's microdose option (our calculation: $2,003 vs. $1,548) but includes Noom's behavioral coaching platform and clinician support within the subscription. Noom Med's core program and PlexusDx's microdose land at the same annual figure ($1,548) when medication is excluded, but Noom requires quarterly prepayment while PlexusDx bills monthly with no prepay.

The missing pieces: cancellation deadlines and refund policy

Noom Med's public-facing pages describe what you pay and when you pay it, but they do not answer the operational questions a subscriber needs before committing to a prepaid quarter:

• Cancellation notice period: Must you cancel a certain number of days before the next quarterly charge, or can you cancel at any point within the cycle?
• Refund or proration: If you cancel midway through a prepaid quarter, do you receive a prorated refund for unused weeks, or does access continue through the end of the paid period with no money back?
• Auto-renewal: Does the subscription automatically renew at the end of each quarter, and if so, how do you opt out?
• Early termination fees: Are there penalties for ending the subscription before a minimum commitment period?

Our verification session on September 4, 2026 captured Noom Med's pricing pages, FAQ sections accessible without login, and representative product-detail pages. None of these resources published explicit cancellation deadlines or refund terms. It is possible that cancellation policies appear in the terms of service at account creation, in confirmation emails after signup, or in response to support inquiries, but those documents were not available for this review.

If transparent exit terms matter to your decision—particularly if you are uncertain about medication tolerance, efficacy, or the fit of Noom's coaching model—contact Noom Med support before subscribing and request written confirmation of the cancellation process and any applicable refund policy.

Prepayment vs. month-to-month: decision factors

Quarterly prepayment can lower per-month cost and signal commitment, which some providers use to fund deeper coaching resources. It also reduces administrative overhead and aligns billing with longer clinical cycles. The trade-off is reduced liquidity and less flexibility if circumstances change—illness, financial pressure, side effects that require switching medications, or dissatisfaction with the service.

Month-to-month billing costs slightly more in some models but allows you to stop or pause without forfeiting prepaid funds. For weight management, where medication tolerance and response vary widely and where life events often disrupt adherence, monthly flexibility can be worth the incremental cost.

Noom Med's behavioral platform—daily lessons, food logging, one-on-one coaching, and group support—differentiates it from medication-only programs. If that structure appeals and you are confident in committing 90 days at a time, the quarterly model may suit you. If you want the option to exit cleanly after any single month, a month-to-month provider eliminates the prepayment risk.

First-month-to-standard price jumps

Noom Med's microdose first-month rate of $79 (captured September 4, 2026) transitions to $179 per month ongoing—a $100 increase. Expressed as a percentage, the standard rate is 127% higher than the first-month rate (our calculation). The first-month period covers approximately seven weeks, so the price change arrives quickly.

First-month pricing is a common acquisition tool, but the size and speed of the jump matter. If your budget accommodates $79 but not $179, or if you planned to try microdosing for one or two months before committing, confirm with Noom Med whether you can pause or downgrade after the first-month period ends, and whether doing so forfeits access to future first-month rates if you return later.

PlexusDx's microdose GLP-1 protocol is priced at $129 per month from the start with no first-month discount and no price step-up. That figure is $50 per month lower than Noom Med's ongoing microdose rate and $50 higher than Noom Med's first-month rate, landing between the two and eliminating surprise.

Medication inclusion and exclusion

Noom Med's core clinical program—the $387 quarterly subscription—excludes medication cost. You pay separately for your prescription, whether branded or compounded, based on formulary and insurance status. The microdose GLP-1Rx track, by contrast, bundles medication into the subscription fee during both the first-month and ongoing periods.

PlexusDx includes medication in every published price: $129/month for microdose, $189/month for semaglutide injection month-to-month, $289/month for tirzepatide injection month-to-month, with lower per-month rates available on prepaid three-month and six-month plans. There are no separate medication invoices, no pharmacy copay, and no formulary-tier guessing. The listed price is the total recurring cost.

If you are comparing Noom Med's core program to another provider, add your expected monthly medication cost to the $129 program fee to arrive at an apples-to-apples figure. Branded semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) list over $1,000 per month without insurance; compounded semaglutide typically ranges from $200 to $400 per month depending on dose and pharmacy. Noom Med offers compounded options under its GLP-1Rx Plus and microdose programs, but specific compounded pricing for standard-dose semaglutide or tirzepatide was not captured in our review.

Choose Noom Med if…

• You want Noom's established behavioral-change platform—daily curriculum, food logging, and one-on-one coaching—integrated with GLP-1 prescribing.
• You are comfortable with quarterly prepayment and confident you will remain enrolled for at least 90 days per cycle.
• You prefer a large, venture-backed company with a broad user base; Noom Med holds a 4.5-star rating on Trustpilot across 67,000 reviews (profile-wide, not GLP-1-specific; captured September 4, 2026).
• You are interested in the microdose GLP-1 approach and value the first-month $79 rate as a low-cost trial, understanding that the ongoing rate steps to $179/month.
• You are willing to contact support before subscribing to clarify cancellation mechanics and refund policies, since those terms are not published on public pricing pages.

Choose PlexusDx if…

• You want month-to-month billing with no prepaid quarters, allowing you to stop after any single month without forfeiting unused subscription fees.
• You prefer all-inclusive pricing—medication, provider visits, labs (when clinically indicated), and shipping bundled into one monthly charge with no separate pharmacy bills.
• You value pricing transparency and want to know the total recurring cost before starting, with no first-month rate that jumps after the first period.
• You want access to both standard-dose GLP-1 (semaglutide and tirzepatide injections or oral capsules) and microdose protocols under one provider, with the flexibility to switch between options if your clinical needs or budget changes.
• You want a provider that works exclusively with 503A compounding pharmacies and states its compounding model clearly in public materials.

Methodology and freshness

This comparison draws from Noom Med's public pricing pages, FAQ sections, and product-detail pages captured September 4, 2026 during a structured verification session. We recorded advertised rates, billing cadences, and inclusions/exclusions as presented to a prospective subscriber browsing without an account. Cancellation policies, refund terms, and mid-cycle termination mechanics were not published in the captured materials.

Twelve-month cost totals, per-month averages, and percentage comparisons are our calculation based on the captured rates. PlexusDx pricing is current as of September 23, 2026 and reflects the company's standing month-to-month, three-month, and six-month rates published at plexusdx.com. The PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star or higher) was captured September 9, 2026 from trustpilot.com/review/plexusdx.com. The Noom Med Trustpilot rating (4.5 stars, 67,000 reviews) was captured September 4, 2026 and reflects the entire Noom platform, not solely the GLP-1 programs.

Pricing, policies, and program details change. Confirm current terms, cancellation procedures, and medication costs directly with each provider before subscribing.

Frequently Asked Questions

Does Noom Med allow you to cancel before the next quarterly charge?

Noom Med's public pricing pages do not specify a cancellation notice period or deadline. The core program uses quarterly prepayment after the first month, but whether you can cancel mid-cycle, receive a prorated refund, or must wait until the end of the paid quarter is not disclosed in public materials. Contact Noom Med support for written confirmation before subscribing.

Is medication included in Noom Med's $129 monthly fee?

No. The $129-per-month core clinical program fee (billed quarterly as $387) covers behavioral coaching, clinician access, and program support, but medication is billed separately. Noom Med's microdose GLP-1Rx track includes medication in the subscription fee ($79 first-month rate, $179 ongoing rate), but the core program does not.

Can you switch from Noom Med's microdose program to a standard-dose GLP-1 if needed?

Noom Med offers branded injections and compounded GLP-1Rx programs in addition to microdose, but the mechanics of switching between tracks—whether it requires a new subscription, incurs a fee, or resets billing cycles—are not described in public materials. Confirm with Noom Med support if you anticipate needing to escalate dose or change formulations.

Does PlexusDx require quarterly prepayment like Noom Med's core program?

No. PlexusDx offers month-to-month billing on all medication protocols with no quarterly commitment. You can also prepay for three or six months to lower the per-month rate ($169/month for three-month semaglutide injection, $149/month for six-month), but prepayment is optional and month-to-month remains available at the standard rate.

What happens if you cancel mid-cycle with a prepaid provider?

Refund and proration policies vary by provider. Some grant prorated refunds for unused weeks; others continue access through the end of the paid period but issue no refund; still others forfeit the prepaid amount entirely. Noom Med does not publish this policy on its pricing pages. PlexusDx's month-to-month model avoids the question—each month's charge covers only that month, and stopping ends future billing with no prepaid balance at risk.

Sources

• Noom Med public pricing pages, FAQ sections, and product-detail pages (captured September 4, 2026)
• PlexusDx pricing and program details, plexusdx.com (accessed September 23, 2026)
• Noom Med Trustpilot profile (4.5 stars, 67,000 reviews; captured September 4, 2026)
• PlexusDx Trustpilot profile (4.3 stars; captured September 9, 2026; trustpilot.com/review/plexusdx.com)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.